Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Groin or thigh aching in someone on long-term bisphosphonate therapy can signal an atypical femoral fracture, a rare stress fracture of the outer femur shaft that develops before the bone breaks completely. There are several factors to consider. See below to understand more.
Warning pain is often dull, activity-related, and may affect both legs, so imaging of both femurs is recommended, and a normal early X-ray does not rule it out since MRI or bone scan may be needed. Because roughly half of people report prodromal pain weeks to months before a complete break, prompt evaluation can allow protective weight-bearing, drug reassessment, and surgical stabilization before a low-energy fall shatters the bone. Any new groin, hip, or thigh ache after several years of bisphosphonate use deserves a same-week medical review rather than watchful waiting.
If you are unsure whether your symptoms fit this pattern or something more common like tendinopathy or osteoarthritis, a free, instant, online symptom check can help you organize your symptoms and understand which next steps make sense.
Last reviewed for medical accuracy: 08/18/2026
Long-term bisphosphonate therapy—commonly prescribed for osteoporosis and secondary prevention of fractures—can be a critical ally in maintaining bone strength. Yet, after five years or more of use, patients may experience a subtle but serious warning sign: Atypical femur fracture premonitory pain in groin. Recognizing this red flag and obtaining prompt imaging can prevent a complete femur fracture, which often requires major surgery and prolonged rehabilitation.
Atypical femur fractures are rare breaks that differ in location and pattern from the usual hip or wrist fractures seen in osteoporosis. Key features include:
AFFs typically occur in the subtrochanteric region (just below the hip) or along the femoral shaft. Early on, they cause Atypical femur fracture premonitory pain in groin, thigh, or hip—often dull and gradually increasing over weeks or months.
Patients and clinicians sometimes dismiss groin or thigh aches as muscle strain, arthritis, or bursitis. In long-term bisphosphonate users, however, persistent pain in these areas should raise suspicion for an impending atypical fracture.
Signs to watch for:
Ignoring these “prodromal” aches can allow an incomplete stress reaction to progress to a complete break, leading to sudden collapse and severe disability.
While AFFs remain uncommon, certain factors amplify risk:
Talk openly with your doctor about these risks—especially if you’ve been taking alendronate, risedronate, zoledronic acid, or ibandronate for years.
Any patient on long-term bisphosphonates reporting persistent groin or thigh pain should undergo imaging promptly. The preferred first step is a plain radiograph of the entire femur, including:
X-ray may reveal cortical thickening, a faint fracture line, or “beaking.” If X-rays are inconclusive but clinical suspicion remains high, advanced imaging (MRI or bone scan) can detect stress reactions before a full break.
On X-ray, look for:
MRI or bone scan can show increased uptake or marrow edema consistent with an evolving stress injury.
Once an incomplete AFF or stress reaction is identified, early intervention can prevent progression:
For complete AFFs, surgical fixation (nail or plate) is standard. Post-operative care includes non-weight-bearing restrictions and close monitoring.
Bisphosphonates reduce the risk of common osteoporotic fractures—hip, spine, and wrist—by up to 50%. Most patients tolerate them well for 3–5 years. After that, your doctor may recommend a “drug holiday” while monitoring bone density and symptoms closely.
Key takeaways:
If you’re unsure whether your symptoms warrant further investigation, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a quick way to evaluate your groin or thigh pain and decide if medical attention is needed.
Persistent groin aches in long-term bisphosphonate users are not “just arthritis.” They can signal an Atypical femur fracture premonitory pain in groin, the precursor to a serious bone break. Early recognition and prompt X-rays can mean the difference between a minor intervention and major surgery.
Always speak to a doctor about any pain that’s new, worsening, or affecting your daily life—especially if you’ve been on bisphosphonates for five years or more. Early action keeps bones strong and prevents unexpected fractures.
(References)
* Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996 Dec 7;348(9041):1535-41. doi: 10.1016/s0140-6736(96)07088-2. PMID: 8950879.
* Gielen E, Vanderschueren D, Callewaert F, Boonen S. Osteoporosis in men. Best Pract Res Clin Endocrinol Metab. 2011 Apr;25(2):321-35. doi: 10.1016/j.beem.2010.08.012. PMID: 21397201.
* Buck G, Perger L, Bischoff-Ferrari HA. [Osteoporosis]. Praxis (Bern 1994). 2011 Jul 6;100(14):821-32. doi: 10.1024/1661-8157/a000599. PMID: 21732293.
* Tandjung R, Rosemann T. [Post hip fracture care]. Praxis (Bern 1994). 2011 Jul 27;100(15):917-21. doi: 10.1024/1661-8157/a000614. PMID: 21792807.
* Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Howe TS, van der Meulen MC, Weinstein RS, Whyte MP. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014 Jan;29(1):1-23. doi: 10.1002/jbmr.1998. Epub 2013 Oct 1. PMID: 23712442.
* Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, Pignolo RJ, Sellmeyer DE. Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2016 Jan;31(1):16-35. doi: 10.1002/jbmr.2708. PMID: 26350171; PMCID: PMC4906542.
* Khan AA, Kaiser S. Atypical femoral fracture. CMAJ. 2017 Apr 10;189(14):E542. doi: 10.1503/cmaj.160450. PMID: 28396331; PMCID: PMC5386848.
* Yano Y, Kuriyama A, Yano Y, Takeshita A, Hashizume H. Atypical femoral fracture with bisphosphonate use. QJM. 2020 Nov 1;113(11):825-826. doi: 10.1093/qjmed/hcaa073. PMID: 32091607.
* Black DM, Geiger EJ, Eastell R, Vittinghoff E, Li BH, Ryan DS, Dell RM, Adams AL. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. N Engl J Med. 2020 Aug 20;383(8):743-753. doi: 10.1056/NEJMoa1916525. PMID: 32813950; PMCID: PMC9632334.
* Lo JC, Grimsrud CD. Identifying Complete Atypical Femur Fractures in Adults with Bisphosphonate Exposure. Endocr Pract. 2024 Mar;30(3):278-281. doi: 10.1016/j.eprac.2023.12.012. Epub 2023 Dec 16. PMID: 38110088; PMCID: PMC10950361.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.